---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-026437"
form_type: "8-K"
ticker: "RGNX"
cik: "0001590877"
company_name: "REGENXBIO Inc."
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:22:05.984475+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# REGENXBIO shareholders elect all three Class II director nominees at annual meeting

## Summary
- Jean Bennett, Jerry Karabelas, and Daniel Tassé elected as Class II directors with 30.3M, 35.5M, and 36.0M votes for, respectively.
- Ratification of PricewaterhouseCoopers as independent auditor for FY2023 approved: 39.8M for, 50.7K against.
- Advisory (non-binding) vote on named executive officer compensation passed with 36.7M for, 1.1M against.
- Broker non-votes were 1,965,878 for director election and say-on-pay; none for auditor ratification.

## SEC filing metadata
- accession: 0000950170-23-026437
- form_type: 8-K
- ticker: RGNX
- cik: 0001590877
- company_name: REGENXBIO Inc.
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/rgnx-20230602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-026437
- JSON: https://secwatch.observer/filing/0000950170-23-026437.json
- Plain text: https://secwatch.observer/filing/0000950170-23-026437.txt

## Key facts
- Shareholder Votes
  REGENXBIO Inc. shareholders approved Advisory vote to approve named executive officer compensation at the 2023-06-02 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-02
  source text: Proposal 3 : By the following vote, the stockholders approved, on an advisory basis,the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement: Votes For Votes Against Votes Abstaining Broker Non-Votes 36,733,345 1,131,884 111,321 1,965,878
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm
- Shareholder Votes
  REGENXBIO Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-06-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-02
  source text: Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023: Votes For Votes Against Votes Abstaining Broker Non-Votes 39,799,734 50,694 92,000 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm
- Shareholder Votes
  REGENXBIO Inc. shareholders approved Election of three Class II directors at the 2023-06-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-02
  source text: Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company’s 2026 annual meeting of stockholders: Nominee Votes For Votes Withheld Broker Non-Votes Jean Bennett, M.D., Ph.D. 30,318,877 7,665,786 1,965,878 A.N. “Jerry” Karabelas, Ph.D. 35,490,395 2,494,268 1,965,878 Daniel Tassé 35,984,653 2,000,010 1,965,878
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.